Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population

Stroke and Vascular Neurology

article

Yilong Wang¹  Shangrong Han¹  Haiqiang Qin¹  Huaguang Zheng¹  Bin Jiang³  Yong Cao²  Yuan Gao⁶  Ling Guan¹  Qian Jia¹  Yong Jiang¹  Yuming Jiao²  Shuya Li¹  Yapeng Li⁶  Zixiao Li¹  Wei Liu⁷  Xiaojuan Ru³  Dongling Sun³  Haixin Sun³  Penglian Wang¹  Tingting Wang¹  Lixia Zong¹  Lei Guo¹  Xuewei Xie¹  Yuming Xu⁶  Yuyuan Xu¹  Xiaomeng Yang¹  Yingying Yang¹  Mengyuan Zhou¹  Wenzhi Wang³ 

[1] Department of Neurology , Beijing Tiantan Hospital, Capital Medical University;China National Clinical Research Center for Neurological Diseases;Department of Neuroepidemiology , Beijing Neurosurgical Institute, Capital Medical University;Beijing Municipal Key Laboratory of Clinical Epidemiology;Department of Neurosurgery , Beijing Tiantan Hospital, Capital Medical University;Neurology , Zhengzhou University First Affiliated Hospital;Department of Neurology , Beijing Haidian Hospital

关键词: stroke;    atherosclerosis;    blood pressure;    platelets;   

DOI  :  10.1136/svn-2020-000385

学科分类：社会科学、人文和艺术（综合）

来源: BMJ Publishing Group

【 摘 要 】

Aim Cerebrovascular disease is the leading cause of death and disability in China, causing a huge burden among patients and their families. Hence, stroke prevention is critical, especially in the high-risk population. Here, we present the evidence-based guideline suitable for the Chinese population.Methods Literature search of PubMed and Cochrane library (from January 1964 to June 2019) was done. After thorough discussion among the writing group members, recommendations were listed and summarised. This guideline was reviewed and discussed by the fellow writing committees of the Chinese Stroke Association’s Stroke.Results This evidence-based guideline was written in three parts: controlling the risk factors of stroke, utilisation of antiplatelet agents and assessing the risks of first-ever stroke. All recommendations were listed along with the recommending classes and levels of evidence.Conclusions This guideline provides recommendations for primary prevention of cerebrovascular disease among high-risk population in China. Controlling related risk factors, appropriately using antiplatelet agents, assessing the risk of developing first-ever stroke should help reduce the rate of cerebrovascular disease in China.

【 授权许可】

CC BY-NC|CC BY|CC BY-NC-ND